STAT3 and neoplasm: Mice treated during the initial stages of tumorigenesis displayed significant reduction in tumor burden, reprogramming of the TIME chemokine profile, and augmented dendritic cell (DC) and Th1 responses, supporting the hypothesis that STAT3 contributes to early-stage KM-LUAD development.